|  Help  |  About  |  Contact Us

Publication : Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17.

First Author  Sahin U Year  2007
Journal  FEBS Lett Volume  581
Issue  1 Pages  41-4
PubMed ID  17169360 Mgi Jnum  J:117695
Mgi Id  MGI:3697267 Doi  10.1016/j.febslet.2006.11.074
Citation  Sahin U, et al. (2007) Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17. FEBS Lett 581(1):41-4
abstractText  All ligands of the epidermal growth factor receptor (EGFR), which has important roles in development and disease, are made as transmembrane precursors. Proteolytic processing by ADAMs (a disintegrin and metalloprotease) regulates the bioavailability of several EGFR-ligands, yet little is known about the enzyme responsible for processing the recently identified EGFR ligand, epigen. Here we show that ectodomain shedding of epigen requires ADAM17, which can be stimulated by phorbol esters, phosphatase inhibitors and calcium influx. These results suggest that ADAM17 might be a good target to block the release of bioactive epigen, a highly mitogenic ligand of the EGFR which has been implicated in wound healing and cancer.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Authors

2 Bio Entities

0 Expression